Corvus Pharmaceuticals CRVS
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.70 | 105.19 | -0.15 | -12,217 | -12 | |
| 2025Q3 | 7.37 | 107.50 | -0.12 | -10,572 | -10 | |
| 2025Q2 | 4.00 | 134.84 | -0.13 | -10,260 | -8 | |
| 2025Q1 | 3.18 | -63.07 | -0.13 | -9,922 | 15 | |
| 2024Q4 | 5.35 | 81.55 | -0.16 | -8,105 | -12 | |
| 2024Q3 | 5.28 | 18.35 | -0.68 | -7,255 | -40 | |
| 2024Q2 | 1.82 | 161.06 | -0.06 | -5,935 | -4 | |
| 2024Q1 | 1.78 | 105.32 | -0.12 | -6,253 | -6 | |
| 2023Q4 | 1.76 | 107.66 | -0.13 | -5,651 | -7 | |
| 2023Q3 | 1.46 | 108.28 | -0.12 | -5,560 | -6 | |
| 2023Q2 | 2.29 | 107.72 | -0.14 | -5,622 | -7 | |
| 2023Q1 | 0.91 | 107.03 | -0.17 | -6,574 | -8 | |
| 2022Q4 | 0.85 | 109.42 | -0.21 | -5,666 | -10 | |
| 2022Q3 | 0.82 | 103.07 | -0.32 | -12,473 | -15 | |
| 2022Q2 | 0.99 | 103.64 | -0.18 | -7,013 | -8 | |
| 2022Q1 | 1.64 | 102.16 | -0.18 | -7,413 | -8 | |
| 2021Q4 | 2.41 | 101.99 | -0.19 | -6,810 | -9 | |
| 2021Q3 | 4.84 | 100.93 | -0.23 | -9,047 | -11 | |
| 2021Q2 | 2.67 | -0.27 | -11,290 | -12 | ||
| 2021Q1 | 3.08 | -0.34 | -11,483 | -12 |